Sino Biopharmaceutical China CDE accepts NDA for TQB2102 injection
TradingView News reports that Sino Biopharmaceutical Limited (HKEX:1177) said China’s CDE accepted its new drug application for TQB2102 injection.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.